Monday, June 2, 2014

NEWS - 30


Salus Alpha managed futures strat surges to 17% YTD

By Matt Smith

Salus Alpha has defied the struggles of the trend-following sector to return nearly 17% in its managed futures strategy over the first five months of the year, latest returns show.
The Salus Alpha Directional Markets strategy, which manages roughly $240m, hit a third consecutive month of gains in May, up 2.54%, to bring its YTD advance to 16.8%.
It comes as average YTD returns for the largest CTA managers climb into the black for the first time this year, according to Newedge’s benchmark index. However the largest trend-followers remain, on average, in the red.
Liechtenstein based Salus Alpha Capital, a pioneer in developing Ucits hedge funds, believes that while the principle role of managed futures strategies is diversification rather than equity outperformance, they should be capable of generating positive return in the current environment.
Low interest rates, the risk on/risk off environment, trendless zigzagging equity markets, volatile commodities and a difficult bond market, have been variously cited as reasons for lacklustre managed futures returns this year.
CIO Oliver Prock said: “I cannot share in widespread complaints about the recent environment since trends that you can identify and profit from are clearly there.
“Our approach is very different to most CTA’s and is designed not only to provide huge insurance payoffs in times of stress but also enables us to make positive returns in market environments that seem to be tough for our peers.
“Our ability to generate returns in seemingly tough market conditions is like taking out car insurance but having your premium more than just repaid when you don’t make a claim.”
Salus’ Directional Markets Strategy is fully systematic and adaptive to market environments, switching between trend-following and contrarian approaches and short and long term time frames across 100 futures markets worldwide.
The strategy is offered on Deutsche Bank’s dbSelect platform or as an Ucits fund gaining exposure to eligible components of the Vienna Stock Exchange listed DMX – Directional Markets Index.

Monday, April 21, 2014

NEWS - 29

Salus Alpha Diversified CTA "Directional Markets" continues to outperform the market. Performance is Ranked #1 in 2014 ytd by db Select Managed Account Platform.

(Vienna / Mauren, 2014-04-15) The Salus Alpha diversified CTA strategy "Directional Markets" (DMXUSD) has delivered an outstanding start to 2014 in terms of performance, according to the db select Manager Performance Flash Report – March 2014, produced by leading Deutsche Bank independent Managed Investment Platform db Select.
The strategy delivered +4.12% in March 2014 which led to the result of being Ranked 1st YTD 2014 and Ranked 3rd Trailing 12 Month return of established managers on DB Select Platform and therefore yet again outperforming the world's biggest CTA managers. The significantly below average trailing 12 Month Volatility of 11.47% provides clear evidence that Directional Markets' risk management is dealing with the current environment and is producing very strong risk-adjusted as well as absolute returns to investors. Regarding current market conditions we expect the strong performance to continue since at the time of writing YTD performance reached already 12% by Mid April. We remain highly uncorrelated to other CTAs, which means a an improvement in returns and risk ratios for e.g multi manager portfolio.
Mr. Prock, CEO and CIO of Salus Alpha Capital said:  
"Investors have asked whether we have changed anything but what we have done is think about when we run our model and when we execute our trades. We have not changed the model at all. The model has consistently performed every year since inception in 2003. Effectively, we have merely put on the traction control so that we can apply the power of our engine to the track"

CTA & Global Macro Manager Name
2014 YTD Return
Trailing 12 Month Return
Trailing 12 Month Sharpe Ratio
Salus Alpha Directional Markets Strategy (DMXUSD)
7.30%
5.46%
0.48
NuWave Combined Futures Portfolio 2x
-2.69%
-4.47%
-0.43
Winton
-0.40%
4.74%
0.55
Brevan Howard Systematic Trading Program *
-6.32%
-5.63%
-0.61
Aspect Diversified Programme
-5.02%
-8.64%
-0.74
Lynx
-5.02%
1.37%
0.08
Table 1 – Performance comparison (dbSelect Manager Performance Flash Report - March 2014)

About Salus Alpha

Salus Alpha Capital is a sophisticated Investment Manager and has established itself as a top expert in Alpha and Smart Beta Asset Management over the past decade. Our extensive Know-How in the space is characteristic of our company and our employees. The client base of Salus Alpha consists of institutional clients in Europe, Asia and in the USA. Salus Alpha operates from a network of global offices including Switzerland, Liechtenstein, Austria, the Netherlands, Singapore, India, and Hong Kong. We offer tailored solutions for clients and their financial needs, such as white label funds, managed accounts and structured products. For more information on Salus Alpha Capital, please visit http://sac.salusalpha.com 

For inquiries please contact either Andrea Moritz or speak to your individual contact within the firm
Andrea Moritz
+43 1 9572587 43

Monday, March 3, 2014

NEWS - 28

Salus Alpha Special Situation Fund delivers strong returns


Salus Alpha RN Special Situation fund had delivered a good start to 2014 in terms of performance, according to the EXANE Report titled “Absolute Return UCITS Fund Performances – February 2014”, produced by Exane Derivatives Europe’s leading convertible research provider.

The Salus Alpha RN Special Situations fund delivered positive returns during the month of January, (Ranked 2nd out of 19 listed in the Exane Report under Event Driven UCITS) it was up by +1.90% and outperformed major peers by a positive margin of 1.35% on average during the month. The fund also enjoyed positive performance in 2013 contrary to most UCITS. Our fund was able to successfully withstand the major corrections in the equity markets taking advantage of volatility resulted from weak fundamentals across the globe. Market sentiment weakened further towards the end of the month, as the Federal Reserve announced another round of tapering which raised concerns regarding the health of the global recovery.

Mr. Prock, CEO and CIO of Salus Alpha Capital said:
“Our fund seem to repeat the January stint in February and in the coming months because our approach is unique and able to generate positive returns in all environments, since it combines an opportunistic core portfolio of selected, fundamentally attractively valued top companies with positions in short / medium - termed special situations and also the fund targets to achieve an absolute return independent of the development of the overall equity market. Therefore we are not dependant on trend as a sole source of alpha”.

About Salus Alpha

Salus Alpha Capital is a sophisticated Investment Manager and has established itself as a top expert in Alpha and Smart Beta Asset Management over the past decade. Our extensive Know-How in the space is characteristic of our company and our employees. The client base of Salus Alpha consists of institutional clients in Europe, Asia and in the USA. Salus Alpha operates from a network of global offices including Switzerland, Liechtenstein, Austria, the Netherlands, Singapore, India, and Hong Kong. We offer tailored solutions for clients and their financial needs, such as white label funds, managed accounts and structured products. For more information on Salus Alpha Capital, please visit http://sac.salusalpha.com/

For inquiries please contact
Andrea Moritz
+43 1 9572587 43

Appendix –

Rank
Event Driven UCITS
YTD Performance
1
MLIS - York Event Driven Ucits Fund
4.00%
2
Salus Alpha RN Special Situations
1.90%
3
MS PSAM Global Event UCITS Fund
1.80%
4
Dexia Risk Arbitrage
1.10%
5
Syquant Helium Performance
1.10%
6
Syquant Helium Opportunites
0.70%
7
CS Tremont Hedge Fund Risk Arbitrage
0.50%
8
Laffitte Risk Arbitrage
0.50%
9
Cigogne UCITS M&A Arbitrage
0.40%
10
Dexia Money + Risk Arbitrage
0.40%
11
ADI Risk Arbitrage Absolute Return
0.30%
12
CS Tremont Hedge Fund Event Driven
0.30%
13
Lutetia Patrimoine fund
0.30%
14
ADI Risk Arbitrages
0.10%
15
JP Morgan Global Merger Arbitrage Fund
0.10%
16
Pinebridge Merger Arbitrage Fund
0.00%
17
Westchester Merger Arbitrage
-0.30%
18
The Castlerigg Merger Arbitrage UCITS Fund
-0.50%
19
York Lion Merger Arbitrage Liquidity Fund UI
-0.90%
Table 1 – Performance comparison (Exane Derivatives - Absolute Return UCITS Fund Performances – February 2014)

Link - 1LinK - 2

Tuesday, February 18, 2014

NEWS - 27

Salus Alpha’s Strategies deliver strong start to 2014

(Vienna / Mauren, 2014-02-19) Salus Alpha’s strategies have delivered a good start to 2014 in terms of performance, according to the DB select Manager Performance Flash Report – January 2014, produced by leading independent Managed Investment Platform db Select.

The strategies delivered positive returns during the month of January, led by the Salus Alpha Directional Markets Strategy (DMXUSD) (Ranked 3rd out of 69 listed CTA programmes on DB Select Platform) which was up +5.75% and outperforming the world biggest CTA power houses by a positive margin of 6.5% on average during the month. Further, the Salus Alpha Global Alpha Strategy (GAXUSD) (Ranked 8th out of 69 listed CTA programmes on DB Select Platform) was up by +2.08% in January. Both programmes enjoyed also positive performance in 2013 contrary to most CTAs. Our programmes were able to take advantage of volatility which is back in the markets due to volatile fundamental data led by weak US jobs and discouraging PMI numbers from China. Market sentiment weakened further towards the end of the month, as the Federal Reserve announced another round of tapering which raised concerns regarding the health of the global recovery.

Mr. Prock, CEO and CIO of Salus Alpha Capital said:

“Our strategies seem to repeat the January stint in February and in the coming months because our approach is unique and able to generate positive returns in all environments, since it is adaptive to changing market environments and can switch between short to long term as well as trend following and contrarian. Therefore we are not dependent on trend as a sole source of alpha”.

CTA & Global Macro Manager Name
Jan-14 Month Return
Trailing 12 Month Volatility
Trailing 12 Month Sharpe Ratio
Salus Alpha Directional Markets Strategy (DMXUSD)
5.75%
11.07%
0.31
Salus Alpha Global Alpha Strategy (GAXUSD)
2.08%
10.82%
0.41
NuWave Combined Futures Portfolio 2x
-2.25%
9.87%
-0.57
Winton
-2.40%
8.65%
0.54
Brevan Howard Systematic Trading Program *
-4.81%
9.57%
-0.51
Aspect Diversified Programme
-5.52%
12.19%
-0.88
Lynx
-5.89%
16.55%
0.07
Chesapeake Diversified Program
-7.60%
20.93%
0.67
Table 1 – Performance comparison (dbSelect Manager Performance Flash Report - January 2014)

About Salus Alpha

Salus Alpha Capital is a sophisticated Investment Manager and has established itself as a top expert in Alpha and Smart Beta Asset Management over the past decade. Our extensive Know-How in the space is characteristic of our company and our employees. The client base of Salus Alpha consists of institutional clients in Europe, Asia and in the USA. Salus Alpha operates from a network of global offices including Switzerland, Liechtenstein, Austria, the Netherlands, Singapore, India, and Hong Kong. We offer tailored solutions for clients and their financial needs, such as white label funds, managed accounts and structured products. For more information on Salus Alpha Capital, please visit http://sac.salusalpha.com/

For inquiries please contact
Andrea Moritz
+43 1 9572587 43

Link 1Link 2

Thursday, December 20, 2012

NEWS - 26

Salus Alpha Analyst Award 2012

Analyst Award for courage and innovation
(LEFT TO RIGHT) Christian Drastil (Christian Drastil Comm.), Franz Hörl (Erste Group), Stefan Maxian (RCB), Günther Schneider (Salus Alpha), Thomas Neuhold (Kepler), Christine Reitsamer (Baader Bank), Richard Schenz (Kapitalmarktbeauftragter)

(Vienna/Mauren) On the 12th December 2012 the exclusive location of the Viennese “Haus der Industrie” became home to the 13th edition of the Salus Alpha Analyst Award 2012 – an event honoring analysts who have achieved the best research results in the Austrian Equity market. Salus Alpha is the main partner since 2011.

The laudatio was held by Günther Schneider, Head of Global Business Development at Salus Alpha: „We are proud of such excellent analysts, of their courage and innovation. We have once again looked for the best and we are proud to say we found them. Analysts who see themselves solely as advisor of the customer, thus, of the fund and asset manager, and who act accordingly have to be supported. At the end of the day you have to be more than just a good analyst to generate alpha.”

Salus Alpha and the Analyst Award have been connected quite a while. Roland Neuwirth, Fund Manager at Salus Alpha, is a 5-time winner of the Analyst Award. Therefore it was an especially great pleasure for Günther Schneider to present the winners of this year’s ceremony with their awards. The winners included among others Franz Hörl (Erste Group), Stefan Maxian (RCB), Thomas Neuhold (Kepler), Christine Reitsamer (Baader Bank).

About Salus Alpha
Salus Alpha, an Alternative Investments Manager, has established itself as a top expert in quantitative, systematic Asset Management over the past decade. The funds range from Long/Short Equities, Relative Value, Arbitrage to Managed Futures. The company’s extensive Know-How in the field of Alternative Investments is a characteristic of the company. The client base of Salus Alpha consists of institutional clients in Europe and Asia. Up to now the assets under management (AUM) of Salus Alpha have reached 1.1 billion USD. The company operates from a network of global offices including Switzerland, Liechtenstein, Austria, the Netherlands, Singapore, India, Sweden, USA, and Hong Kong. 


For further information on our products or distribution please contact
Salus Alpha Financial Services GmbH, Mag. Günther Schneider
Wegacker 42, 9493 Mauren, Liechtenstein
Tel: +423 399 03 29; invest@salusalpha.com

For further information, charts and graphical material please contact:
Salus Alpha Group Services GmbH, Ms. Jacqueline Nagy
Scherffenberggasse 3/8, 1180 Vienna, Austria
Tel: +43 1 9572587-42 ; public.relations@salusalpha.com